NSE · DBOL
Dhampur Bio Organics Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹554 Cr with net profit ₹38 Cr — a 6.93% net margin, versus 1.18% the period before.
Shareholding
As of 2026-09-30
- Promoter51%
- Public48.08%
- FII0.55%
- DII0.37%
43,834 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.2× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Sugar · ranked #11 of 30 by market cap · medians across 29 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Balrampur Chini Mills Ltd. | ₹13,366 Cr | 36.01 | 2.91 | 9.15% | 5.83% |
| EID Parry (India) Ltd. | ₹11,046 Cr | 13.6 | 1.25 | 9.91% | 1.2% |
| Triveni Engineering and Industries Ltd. | ₹4,991 Cr | 19.06 | 1.49 | 5.91% | 3.66% |
| Bajaj Hindusthan Sugar Limited | ₹4,322 Cr | 33.48 | 4.52 | 3.69% | 2.17% |
| Shree Renuka Sugars Ltd. | ₹3,938 Cr | — | — | 29.59% | -8.42% |
| Dalmia Bharat Sugar & Industries Ltd. | ₹3,329 Cr | 16.23 | 1.03 | 7.3% | 5.82% |
| Uttam Sugar Mills Ltd. | ₹1,249 Cr | 14.2 | 1.43 | 11.44% | 3.99% |
| Dhampur Sugar Mills Ltd. | ₹1,059 Cr | 15.07 | 0.88 | 5.44% | 2.46% |
| Godavari Biorefineries Limited | ₹1,032 Cr | 35.57 | 1.31 | 4.27% | 1.09% |
| M.V.K. Agro Food Product Ltd. | ₹1,004 Cr | 20.27 | 2.23 | 10.35% | 14.02% |
| Dhampur Bio Organics Ltd.(this company) | ₹811 Cr | 31.73 | 0.79 | 3.07% | 2.63% |
AI analysis
AI-generated · google/gemini-2.5-flashDhampur Bio Organics Ltd. is listed with an EPS of 3.85 and a market capitalization of Rs 714 Cr. The company reported revenue of Rs 2141.08 Cr and a profit margin of 263.4%.
Positives
- +The company reported a high profit margin of 263.4%.
- +Return on Equity (ROE) is significantly high at 306.5%.
- +The promoter holding is 50.7839%, indicating significant insider ownership.
- +No promoter shares are pledged (0%).
Negatives
- −Revenue growth for the latest period was negative at -0.2%.
- −The company's Return on Capital Employed (ROCE) is relatively low at 5.05%.
- −The debt-to-equity ratio is 1.09, indicating a reliance on debt financing.
- −Quarterly net profit declined from Rs 46.27 Cr in March 2026 to Rs 36.79 Cr in June 2026.
- −Promoter holding decreased from 50.441% in June 2023 to 50.7839% in June 2026, though specific quarterly changes vary.
Financial Performance
The company's annual revenue was Rs 2141.08 Cr, with a revenue growth of -0.2%. Net profit for March 2026 was Rs 25.18 Cr. Quarterly data shows revenue of Rs 532.89 Cr in June 2026, generating a net profit of Rs 36.79 Cr. This follows a net profit of Rs 46.27 Cr on revenue of Rs 459.56 Cr in March 2026.
Profitability & Returns
Dhampur Bio Organics Ltd. achieved an impressive Return on Equity (ROE) of 306.5%, alongside a Return on Capital Employed (ROCE) of 5.05%. The company's profit margin stood at 263.4%. Its EPS is reported as 3.85.
Balance Sheet
The company's book value per share is Rs 154.64. The debt-to-equity ratio is 1.09, indicating its leverage. Further details on assets and liabilities are not provided in the supplied data.
Ownership & Pledges
As of June 30, 2026, promoter holding was 50.7839%, with public shareholders holding 48.1058%. FIIs held 0.2853% and DIIs held 0.825%. There are no promoter pledges reported (0%). The number of shareholders is 44537.
Data as of — price: 2026-10-27 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.